INVO Fertility, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INVO Fertility, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $62.27K, a 62.29% decline year-over-year.
- INVO Fertility, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $8.75M.
- INVO Fertility, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $165.13K, a 713.57% increase year-over-year.
- INVO Fertility, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. stock issued during period, value, new issues for fiscal 2025 was $12.36M.
- INVO Fertility, Inc. stock issued during period, value, new issues for fiscal 2023 was $5.72M, a 1875.49% increase from fiscal 2022.
- INVO Fertility, Inc. stock issued during period, value, new issues for fiscal 2022 was $289.80K, a 92.06% decline from fiscal 2021.
- INVO Fertility, Inc. stock issued during period, value, new issues for fiscal 2021 was $3.65M, a 68.19% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $12.36M 10-K · filed 2026-06-02 | |
| 2025-06-30 | $62.27K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $8.75M 10-Q · filed 2026-08-14 | |
| 2024-06-30 | $165.13K 10-Q/A · filed 2024-11-19 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $5.72M 10-K · filed 2025-04-30 |
| 2023-09-30 | $3.00M 10-Q · filed 2024-11-19 | $5.73M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $20.30K 10-Q/A · filed 2024-11-19 | $2.70M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-03-31 | $2.71M 10-Q/A · filed 2024-11-19 | $2.68M derived: sum of 4 quarters · filed 2024-11-19 |
| 2022-12-31 | $1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $289.80K 10-K/A · filed 2024-11-19 |
| 2022-09-30 | -$25.20K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | |
| 2022-03-31 | $315.00K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $3.65M 10-K · filed 2022-03-31 | |
| 2020-12-31 | $11.48M 10-K · filed 2021-03-30 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $77.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $30.00K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $47.00K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $54.63K 10-K · filed 2019-04-16 | |
| 2014-12-31 | $20.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |